<- Go Home
Eurofins Scientific SE
Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. It provides services, such as agroscience, including biological assessment, consumer and human, environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, including sustainability, audit, certification, quality inspection, QA-QC programme, and food and dietary supplement labelling services; biopharma, and clinical diagnostics. The company also offers consumer product testing, which include sustainability, testing, certifications and approvals, expert services and regulatory, inspections, audits, consumer research and sensory evaluation, and training courses; cosmetics and personal care; and electrical and electronics laboratories services. In addition, it provides environment testing, including maritime, water, air, soil, building material, pollution, waste, fuel/oil, microplastics, and radioactivity testing; and food and feed testing that include allergen, audit and certification, authenticity, carbohydrates, consulting, dioxins and POPs, food irradiation, GMO, heavy metal, melamine, microbiology, molecular biology, mycotoxin, nutritional analyses, organic contaminants, pesticide, veterinary drug, vitamin, and residual DNA testing. Further, the company provides forensic, genomic, maritime, materials and engineering, REACH, and sensory and consumer services, as well as in vitro diagnostics and PSS insourcing solutions. The company was founded in 1987 and is headquartered in Luxembourg, Luxembourg.
Market Cap
EUR 11.0B
Volume
337.9K
Cash and Equivalents
EUR 791.2M
EBITDA
EUR 1.5B
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
EUR 1.6B
Profit Margin
22.49%
52 Week High
EUR 74.32
52 Week Low
EUR 51.38
Dividend
1.15%
Price / Book Value
3.12
Price / Earnings
28.09
Price / Tangible Book Value
-6.14
Enterprise Value
EUR 14.7B
Enterprise Value / EBITDA
9.08
Operating Income
EUR 963.7M
Return on Equity
9.50%
Return on Assets
5.51
Cash and Short Term Investments
EUR 794.2M
Debt
EUR 4.4B
Equity
EUR 4.6B
Revenue
EUR 7.3B
Unlevered FCF
EUR 584.1M
Sector
Life Sciences Tools and Services
Category
N/A